Log in to search using one of your social media accounts:

 

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
Condition:   Acute Exacerbation of COPD Interventions:   Combination Product: Hemolung Respiratory Assist System;   Device: Invasive mechanical ventilation Sponsor:   Alung Technologies Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2017 Category: Research Source Type: clinical trials

Surface Respiratory Electromyography Measurements During Treadmill Exercise in Stable Patients With COPD
Condition:   Respiratory Disease Intervention:   Diagnostic Test: Exercise testing Sponsor:   Guangzhou Institute of Respiratory Disease Completed - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2017 Category: Research Source Type: clinical trials

Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome
Condition:   Neonatal Respiratory Distress Intervention:   Drug: Misoprostol Sponsor:   Assiut University Recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2017 Category: Research Source Type: clinical trials

Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins Infants
Conditions:   nCPAP;   BiPAP;   Respiratory Distress Syndrome Interventions:   Device: BiPAP;   Device: nCPAP Sponsor:   Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2017 Category: Research Source Type: clinical trials

Trial of Respiratory Infections in Children for Enhanced Diagnostics
Condition:   Community-acquired Pneumonia Intervention:   Sponsors:   Karolinska Institutet;   Stockholm South General Hospital;   Science for Life Laboratory;   Uppsala University;   Astrid Lindgren Children´s Hospital;   Sahlgrenska University Hospital, Sweden;   Turku University Hospital Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2017 Category: Research Source Type: clinical trials

A Study to Investigate the Safety, Tolerability and Efficacy of Inhaled Nebulised Poractant Alfa (Porcine Surfactant Curosurf ®) in Comparison With nCPAP (Nasal Continuous Positive Airway Pressure) Alone in Preterm Neonates With Respiratory Distress Syndrome
Condition:   Neonatal Respiratory Distress Syndrome Interventions:   Drug: nCPAP (nasal Continuous positive airway pressure) + Nebulised Curosurf® (Part I);   Drug: nCPAP (nasal Continuous positive airway pressure) + Nebulised Curosurf® (Part II);   Other: nCPAP (nasal Continuous positive airway pressure) alone (Part I);   Other: nCPAP (nasal Continuous posi tive airway pressure) alone (Part II) Sponsor:   Chiesi Farmaceutici S.p.A. Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2017 Category: Research Source Type: clinical trials